Anna Pickering
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Pickering has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Jayabal Panneerselvam
University of Hawaii Cancer Center; University of Hawaii; Honolulu, HI USA
1 shared publication - Jun Zhang
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, PR China
1 shared publication - Peiwen Fei
Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2013
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 14 (12) , 1089-1091
Advances in the understanding of the Fanconi anemia tumor suppressor pathway
Extremely high cancer incidence in Fanconi anemia (FA) patients has long suggested that the FA signaling pathway is a tumor suppressor pathway. Indeed, our recent findings, for the first time, indicate that the FA pathway plays a significant role in suppressing the development of non-FA human cancer. Also our studies on FA group D2 protein (FANCD2) have, among the first, documented the crosstalks between the FA and Rad6/Rad18 (HHR6) pathways upon DNA damage. In this review, we will discuss how our studies enhance the understanding of the FA tumor suppressor pathway.
- 1 December 2013
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 14 (12) , 1089-1091
Open AccessAdvances in the understanding of the Fanconi anemia tumor suppressor pathway
Extremely high cancer incidence in Fanconi anemia (FA) patients has long suggested that the FA signaling pathway is a tumor suppressor pathway. Indeed, our recent findings, for the first time, indicate that the FA pathway plays a significant role in suppressing the development of non-FA human cancer. Also our studies on FA group D2 protein (FANCD2) have, among the first, documented the crosstalks between the FA and Rad6/Rad18 (HHR6) pathways upon DNA damage. In this review, we will discuss how our studies enhance the understanding of the FA tumor suppressor pathway.